{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C"
        },
        {
          "HGVS": "NM_198578.4:c.6058G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "6058"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_198578.4:c.6061A>C",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "A",
            "alt": "C",
            "position": "6061"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T"
        },
        {
          "HGVS": "NM_198578.4:c.5717A>T",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "A",
            "alt": "T",
            "position": "5717"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "M",
            "position": "1906"
          },
          "Description in input context": "K1906M"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "SF-TAP tagged LRRK2 variants were expressed in HEK293 cells and purified via SF-TAP tandem affinity purification as described earlier"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Roc-domain mutant LRRK2 R1441C showed no significant alteration in its kinase activity."
        },
        {
          "Variant": "NM_198578.4:c.6058G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S and I2020T mutations show an increased phosphotransferase activity towards MKKs correlating with the activity shown for its autophosphorylation."
        },
        {
          "Variant": "NM_198578.4:c.6061A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S and I2020T mutations show an increased phosphotransferase activity towards MKKs correlating with the activity shown for its autophosphorylation."
        },
        {
          "Variant": "NM_198578.4:c.5717A>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "The kinase dead variant of LRRK2, LRRK2 K1906M, served as a negative control and showed no MKK3/6 phosphorylation, demonstrating that the observed phosphorylation is LRRK2-specific."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "wild-type LRRK2"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "kinase dead LRRK2 K1906M"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Pair-wise comparison was performed by Tukey's post-hoc test. LRRK2 phosphorylation was normalised to the average of LRRK2 wild-type phosphorylation levels which were set as 100%."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LRRK2 wild-type phosphorylation levels which were set as 100%.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "increase or decrease in LRRK2 wild-type phosphorylation levels which were set as 100%.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}